Agilent Technologies Inc (A)vsAdvanced Biomed Inc. Common Stock (ADVB)
A
Agilent Technologies Inc
$181.15
-0.18%
HEALTHCARE · Cap: $51.17B
ADVB
Advanced Biomed Inc. Common Stock
$2.64
-11.41%
HEALTHCARE · Cap: $6.58M
Smart Verdict
WallStSmart Research — data-driven comparison
Agilent Technologies Inc generates 5775519% more annual revenue ($7.37B vs $127,640). ADVB leads profitability with a 5231.0% profit margin vs 19.5%. A earns a higher WallStSmart Score of 63/100 (C+).
A
Buy63
out of 100
Grade: C+
ADVB
Avoid30
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-63.8%
Fair Value
$78.68
Current Price
$181.15
$102.47 premium
Intrinsic value data unavailable for ADVB.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 25.6%
Reasonable price relative to book value
Keeps 5231 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
Grey zone — moderate risk
Weak financial health signals
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Market Cap, Operating Margin. Profitability is solid with margins at 19.5% and operating margin at 25.6%. PEG of 1.47 suggests the stock is reasonably priced for its growth.
Bull Case : ADVB
The strongest argument for ADVB centers on Price/Book, Profit Margin, Debt/Equity. Profitability is solid with margins at 5231.0% and operating margin at -3856.0%.
Bear Case : A
The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : ADVB
The primary concerns for ADVB are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
A profiles as a mature stock while ADVB is a value play — different risk/reward profiles.
A is growing revenue faster at 8.1% — sustainability is the question.
A generates stronger free cash flow (439M), providing more financial flexibility.
Monitor DIAGNOSTICS & RESEARCH industry trends, competitive dynamics, and regulatory changes.
Bottom Line
A scores higher overall (63/100 vs 30/100), backed by strong 19.5% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Advanced Biomed Inc. Common Stock
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. The company is headquartered in New York, New York.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?